Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Sun Pharma and Escorts and can sell Indiabulls Real Estate, United Spirits and Strides Shasun.
Chandan Taparia of Motilal Oswal Securities is of the view that one can buy Bajaj Finance and TVS Motor Company while he feels that Sun Pharmaceutical Industries is likely to test Rs 560.
Sun Pharma, Sobha and Tata Motors, among others, are being tracked by investors on Monday.
Sandeep Wagle of powermywealth.com suggests buying Ceat and Sun Pharmaceutical Industries.
Mitessh Thakkar of miteshthacker.com recommends buying Sun Pharma and Escorts.
Shahina Mukadam, Independent Market Expert is of the view that one may hold Sun Pharmaceutical Industries.
Rajat Bose of rajatkbose.com is of the view that one may buy Sun Pharmaceutical Industries.
Natco Pharma rallies in trade as Mylan gets US Food and Drug Administration (US FDA) nod for Copaxone. In an interview to CNBC-TV18, Amey Chalke, Research Analyst at HDFC Securities spoke about the impact and his strategy on the stock.
Ashwani Gujral of ashwanigujral.com advises holding Future Consumer with a stop loss at Rs 50.
Moneycontrol attempts to identify stocks that wise investors should use to duck and weave through this particular storm.
Mitessh Thakkar of mitesshthakkar.com advises selling Dalmia Bharat and Eicher Motors.
Sharmila Joshi of sharmilajoshi.com is of the view that is of the view that one may prefer Glenmark Pharma, Sun Pharmaceutical and Lupin.
Ashwani Gujral of ashwanigujral.com suggests buying Lupin, NBCC and Dewan Housing Finance.
Ashwani Gujral of ashwanigujral.com suggests buying IndusInd Bank, Raymond and CESC and advises holding Yes Bank.
Basant Maheshwari of Basant Maheshwari Wealth is of the view that pharma should be looked at but advises starting from the top notch companies, the bluechips.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can sell MRF, Interglobe Aviation, Amara Raja Batteries and Vedanta and buy Sun Pharmaceutical Industries.
According to Mitessh Thakkar of mitesshthakkar.com, one can sell Apollo Hospitals, Can Fin Home and ICICI Prudential Life and can buy Reliance Defence and Sun Pharma.
Sun Pharma, Jubilant Foodworks and OMCs are being tracked by investors on Thursday.
Prakash Gaba of prakashgaba.com is of the view that market may go into a consolidation. The crucial support for the Nifty is at 10028-9996 and the resistance is at 10138-10150. On the other hand, Bank Nifty has support at 24600 and resistance at 25000-25100.
Vijay Chopra of enochventures.com advices buying Sun Pharma with a target of Rs 530.
Prakash Gaba of prakashgaba.com is of the view that HDFC Bank can climb to Rs 1860 while Sun Pharma may test Rs 530.
The Nifty is expected to continue with similar price-fence unless market witness a major trigger to break out at either side with trading range at the 9835-9995 level.
Watch the interview of Andrew Holland CEO, Avendus Capital and Ashwani Gujral ashwanigujral.com with CNBC-TV18's Prashant Nair and Ekta Batra on CNBC-TV18, in which they shared their reading and outlook on markets and specific stocks.
Ashwani Gujral of ashwanigujral.com recommends selling Idea Cellular, Sun Pharma and Interglobe Aviation and advises buy Titan Company and UltraTech Cement.
Kotak Mahindra Bank, Sun Pharmaceuticals, and United Breweries, among others are on the radar of investors on Wednesday.